Total amount raised
$328 Millions
Latest funding date
February, 2016
Location
Flatiron Health has successfully raised significant funding through multiple rounds, culminating in its acquisition by Roche for $1.9 billion. The company focuses on transforming cancer care by providing innovative solutions that enhance patient experiences and accelerate research.
Keep reading to explore the intricacies of Flatiron Health's fundraising journey and the investors backing this transformative platform.
What Is Flatiron Health?
Flatiron Health, founded in June 2012 by Nat Turner and Zach Weinberg, is a healthcare technology company based in New York, New York. The company focuses on accelerating cancer research and improving patient care by aggregating and transforming clinical and financial data from electronic medical records and billing systems.
Flatiron Health partners with community cancer practices, academic research centers, and therapeutic oncology companies to provide comprehensive support through its database platform. Their mission is to improve lives by learning from the experience of every cancer patient.
With a workforce of 1001-5000 employees, Flatiron Health continues to innovate in the field of oncology, designing better clinical trials, accelerating drug development, and powering smarter care.
How Much Funding Has Flatiron Health Raised?
- Series A
- Amount Raised: $8M
- Date: January 2013
- Lead Investors: Google Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop and launch their initial oncology data platform.
- Series B
- Amount Raised: $130M
- Date: May 2014
- Lead Investors: Google Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand their data platform and enhance their product offerings.
- Series C
- Amount Raised: $175M
- Date: January 2016
- Lead Investors: Roche
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further invest in the OncologyCloud software platform and support value-based care solutions.
- Series D
- Amount Raised: $11.9M
- Date: December 2021
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To continue enhancing their oncology data solutions and support ongoing research initiatives.
Total Amount Raised: $324.9M. Current Valuation: Not publicly disclosed.
Key Investors
- Roche
- Details: Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. It is the world's largest biotech company and a leader in oncology and in-vitro diagnostics.
- Investment Focus Areas: Pharmaceuticals, Diagnostics, Healthcare
- Notable Investments: Foundation Medicine, Genentech, Illumina
- Google Ventures (GV)
- Details: Google Ventures, now known as GV, is the venture capital investment arm of Alphabet Inc. It provides seed, venture, and growth-stage funding to technology companies.
- Investment Focus Areas: Technology, Life Sciences, Consumer Products
- Notable Investments: Uber, Slack, Medium
- Allen & Company
- Details: Allen & Company is a private investment firm known for its involvement in media and technology sectors. The firm has a long history of advising and investing in high-profile companies.
- Investment Focus Areas: Media, Technology, Telecommunications
- Notable Investments: Twitter, Facebook, Alibaba
- Baillie Gifford
- Details: Baillie Gifford is an investment management firm based in Edinburgh, Scotland. It is known for its long-term investment approach and focus on growth companies.
- Investment Focus Areas: Technology, Healthcare, Consumer Goods
- Notable Investments: Tesla, Amazon, Spotify
- Casdin Capital
- Details: Casdin Capital is an investment firm focused on life sciences and healthcare. The firm aims to support companies that are transforming the healthcare landscape.
- Investment Focus Areas: Life Sciences, Healthcare, Biotechnology
- Notable Investments: 10x Genomics, Relay Therapeutics, Tango Therapeutics
What's Next for Flatiron Health?
Flatiron Health stands at the cusp of significant growth opportunities, driven by its collaboration with Roche to enhance the OncologyCloud software platform. This partnership aims to advance personalized medicine and clinical trials, offering a substantial long-term opportunity. The company is also poised to expand its value-based care solutions and develop the next generation of OncoEMR, which could revolutionize oncology care.
Future fundraising efforts may be bolstered by these promising developments, potentially attracting more strategic investments. However, Flatiron Health will need to navigate the evolving healthcare reimbursement landscape and meet stringent regulatory requirements for clinical trials and data usage. Maintaining a competitive edge in the rapidly evolving healthtech industry will also be crucial.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like Flatiron Health and gather other critical business insights. Sign up for free today and unlock the potential to drive your sales efforts with unparalleled data and insights.
